| HGNC Family | Non-coding RNAs |
| Name | microRNA 1260a |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent studies have implicated miR‐1260A as a critical regulator whose dysregulation is associated with diverse pathological conditions. In particular, profiling of circulating microRNAs in influenza patients revealed that miR‐1260 (likely corresponding to miR‐1260A) is among a panel of highly dysregulated miRNAs in whole blood and infected cells, suggesting that it may play a role in modulating host responses during viral infection."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the oncology arena, aberrant expression of miR‐1260A is emerging as a potential biomarker in several cancers. In prostate cancer, for example, miR‐1260 (assumed here to represent miR‐1260A) is significantly overexpressed compared to controls, with bioinformatic analyses linking this miRNA to pathways implicated in cancer progression."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " In breast cancer, plasma levels of miR‐1260A have been reported to be significantly up‐regulated, and pathway analyses suggest its involvement in critical signaling networks such as the Hippo and TGF‑β cascades."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Conversely, in epithelial ovarian cancer, exosomal miR‐1260A levels are markedly decreased, highlighting its potential utility as a diagnostic and prognostic biomarker for this malignancy."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAdding further complexity, recent evidence indicates that miR‐1260A’s sequence is embedded within certain tRNA‐derived fragments (tRFs), suggesting that it may function dually as a canonical miRNA and as part of a tRF‐miRNA system. This dual identity might influence gene regulatory networks in cancer and contribute to its utility as a circulating biomarker."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " Collectively, these findings position miR‐1260A as both a functional regulator and a promising biomarker across different disease contexts, warranting further mechanistic exploration and validation in clinical settings.\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Paul A Tambyah, Sugunavathi Sepramaniam, Jaminah Mohamed Ali, et al. "}, {"type": "b", "children": [{"type": "t", "text": "microRNAs in circulation are altered in response to influenza A virus infection in humans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0076811"}], "href": "https://doi.org/10.1371/journal.pone.0076811"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24116168"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24116168"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Rahma Said, Yoelsis Garcia-Mayea, Nesrine Trabelsi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression patterns and bioinformatic analysis of miR-1260a and miR-1274a in Prostate Cancer Tunisian patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11033-018-4399-x"}], "href": "https://doi.org/10.1007/s11033-018-4399-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30250996"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30250996"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Veronika Holubekova, Zuzana Kolkova, Marian Grendar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pathway Analysis of Selected Circulating miRNAs in Plasma of Breast Cancer Patients: A Preliminary Study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms21197288"}], "href": "https://doi.org/10.3390/ijms21197288"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33023154"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33023154"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Liang Chen, Kangyu Wang, Lei Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Plasma exosomal "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "miR-1260a, miR-7977"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " and "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "miR-192-5p"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " as diagnostic biomarkers in epithelial ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Future Oncol (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2217/fon-2022-0321"}], "href": "https://doi.org/10.2217/fon-2022-0321"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35893704"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35893704"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Shaharbhanu A Hussain, Kunhi Valappil Deepak, Dechamma Pandyanda Nanjappa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Comparative expression analysis of tRF-3001a and tRF-1003 with corresponding miRNAs (miR-1260a and miR-4521) and their network analysis with breast cancer biomarkers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Rep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11033-021-06732-z"}], "href": "https://doi.org/10.1007/s11033-021-06732-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34661810"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34661810"}]}]}]}
|
| Synonyms | MIRN1260, MIR1260, HSA-MIR-1260A, MIR-1260A, HSA-MIR-1260 |
| NCBI Gene ID | 100302236 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR1260A has 257 functional associations with biological entities spanning 4 categories (molecular profile, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 10 datasets.
Click the + buttons to view associations for MIR1260A from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR1260A gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR1260A gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR1260A gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR1260A gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR1260A gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MIR1260A gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MIR1260A gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR1260A gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR1260A gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR1260A gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |